Cargando…
Exploring microRNA Biomarker for Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is among the severe neuro degenerative diseases that lack widely available effective treatments. As the disease progresses, patients lose the control of voluntary muscles. Although the neuronal degeneration is the cause of this disease, the failure mechanism is st...
Autores principales: | Taguchi, Y.-h., Wang, Hsiuying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983737/ https://www.ncbi.nlm.nih.gov/pubmed/29710810 http://dx.doi.org/10.3390/ijms19051318 |
Ejemplares similares
-
Genetic Association between Amyotrophic Lateral Sclerosis and Cancer
por: Taguchi, Y-h., et al.
Publicado: (2017) -
Exploring MicroRNA Biomarkers for Parkinson’s Disease from mRNA Expression Profiles
por: Taguchi, Y-h., et al.
Publicado: (2018) -
MicroRNAs as Biomarkers in Amyotrophic Lateral Sclerosis
por: Ricci, Claudia, et al.
Publicado: (2018) -
MicroRNA-206: A Potential Circulating Biomarker Candidate for Amyotrophic Lateral Sclerosis
por: Toivonen, Janne M., et al.
Publicado: (2014) -
MicroRNA signatures in genetic frontotemporal dementia and amyotrophic lateral sclerosis
por: Kmetzsch, Virgilio, et al.
Publicado: (2022)